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ABSTRACT The C-terminal (CT) toxin domains of contact-dependent growth inhibi-
tion (CDI) CdiA proteins target Gram-negative bacteria and must breach both the
outer and inner membranes of target cells to exert growth inhibitory activity. Here, we
examine two CdiA-CT toxins that exploit the bacterial general protein secretion ma-
chinery after delivery into the periplasm. A Ser281Phe amino acid substitution in trans-
membrane segment 7 of SecY, the universally conserved channel-forming subunit of
the Sec translocon, decreases the cytotoxicity of the membrane depolarizing orphan10
toxin from enterohemorrhagic Escherichia coli EC869. Target cells expressing secYS281F
and lacking either PpiD or YfgM, two SecY auxiliary factors, are fully protected from
CDI-mediated inhibition either by CdiA-CTo10EC869 or by CdiA-CTGN05224, the latter being
an EndoU RNase CdiA toxin from Klebsiella aerogenes GN05224 that has a related cyto-
plasm entry domain. RNase activity of CdiA-CTGN05224 was reduced in secYS281F target
cells and absent in secYS281F DppiD or secYS281F DyfgM target cells during competition
co-cultures. Importantly, an allele-specific mutation in secY (secYG313W) renders DppiD
or DyfgM target cells specifically resistant to CdiA-CTGN05224 but not to CdiA-CTo10EC869,
further suggesting a direct interaction between SecY and the CDI toxins. Our results
provide genetic evidence of a unique confluence between the primary cellular export
route for unfolded polypeptides and the import pathways of two CDI toxins.
IMPORTANCE Many bacterial species interact via direct cell-to-cell contact using CDI
systems, which provide a mechanism to inject toxins that inhibit bacterial growth
into one another. Here, we find that two CDI toxins, one that depolarizes mem-
branes and another that degrades RNA, exploit the universally conserved SecY trans-
locon machinery used to export proteins for target cell entry. Mutations in genes
coding for members of the Sec translocon render cells resistant to these CDI toxins
by blocking their movement into and through target cell membranes. This work lays
the foundation for understanding how CDI toxins interact with the protein export
machinery and has direct relevance to development of new antibiotics that can pen-
etrate bacterial cell envelopes.
KEYWORDS bacterial competition, type V secretion system, membrane potential, type
V secretion, bacterial competition
The Gram-negative bacterial cell envelope imposes a multitiered barrier to themovement of polypeptides, both into and out of the cell. Newly synthesized pro-
teins destined for export travel via dedicated protein secretory pathways, passing
through multicomponent assemblies that span part, or all, of the cell envelope. The
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majority of unfolded polypeptides transit through the Sec translocon, an inner mem-
brane (IM)-embedded heterotrimeric complex formed by SecY, SecE, and SecG.
Secreted proteins are generally translocated posttranslationally by the SecA motor pro-
tein, which uses ATP energy to deliver preprotein to SecYEG. This interaction alters the
conformation of the lateral gate of SecY, unlocking and partially opening a central
channel through SecY to facilitate secretion (1). In contrast, proteins destined for inser-
tion in the IM contain transmembrane a-helices (TMH) that are transferred through the
SecY lateral gate cotranslationally (2). The SecYEG core associates with additional
accessory proteins, including YidC, which aids lateral insertion into the IM, and the
YfgM/PpiD heterodimer, which binds to SecY at sites overlapping YidC and facilitates
protein secretion under some conditions (3). Fully folded protein substrates cross the
IM through the twin-arginine translocation translocase (4). Other proteins, including a
number of bacterial toxins, exit the cell through highly specialized single- or double-
membrane-spanning secretion systems (type 1 secretion system [T1SS] to T6SS) (5–9)
or, in the case of colicins, via cell lysis (10, 11). Once exported, antibacterial toxins must
traverse the envelope of target cells in the reverse direction to gain access to their mo-
lecular targets. Some toxins, such as those delivered by the T6SS, breach the outer
membrane (OM) of recipient cells via the same macromolecular machinery through
which they exited (12, 13). Others, such as the diffusible antibacterial colicin toxins
from Escherichia coli, co-opt OM porins and transporters as well as transperiplasmic
complexes that couple protein entry through the OM with energy from the proton
motive force (PMF) (14, 15). The colicin nuclease ColE9 may utilize an inter-IM/OM
membrane complex for transport of its nuclease domain into the cytosol (16) involving
the IM protease FtsH and charge-dependent interactions with the IM (17).
Bacterial CDI toxins, in contrast to colicins, utilize a number of IM transport proteins to
promote their translocation through the inner lipid bilayer (18). CDI toxins are encoded
within the polymorphic C-terminal domains of filamentous CdiA proteins (ca. 40 to 100 nm),
which are tethered to the OM and extend out from the cell surface (see Fig. S1 at https://
datadryad.org/stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I) (19). CdiA
is exported via the Sec-dependent secretion pathway and assembled on the surface
of CDI1 cells by its T5SS partner and OM transporter, CdiB. CDI systems endow Gram-
negative bacterial cells with growth inhibitory activity against closely related, nonim-
mune bacterial cells through the touch-dependent, receptor-mediated delivery of
the CdiA toxin domain (19–21). Self-intoxication is prevented by expression of CdiI,
which binds specifically to its cognate toxin and neutralizes it (22–25). Among E. coli
CdiA proteins, multiple OM receptors have been identified: the BamA subunit of the
OM b-barrel assembly machine complex, heterotrimers of OmpF/C osmoporins, and
the nucleoside transporter Tsx (26–28). The receptor binding domains (RBDs) of these
CdiAs are located centrally, but recent work indicates that CdiA folds such that the
RBD is located at the tip of a thin hairpin fiber extending out from the cell surface,
with the toxin-containing C-terminal half of CdiA localized within the periplasm (19).
Receptor binding induces a series of conformational changes in CdiA that ultimately
lead to transfer of the C-terminal toxin domain (CdiA-CT) into the periplasmic space
of targets, where it is likely cleaved at or near the common (VE)NN sequence (19, 29).
Genetic selections have identified specific target cell IM proteins (IMPs) that play criti-
cal roles at this step (18, 26, 30). For example, the glucose-specific transporter PtsG is
required for CDI mediated by the C-terminal effector domain of CdiA from E. coli iso-
late EC3006 (CdiAEC3006), a tRNase (18). Target cells lacking PtsG are resistant to deliv-
ered CdiA-CTEC3006 but not to internally expressed toxin, suggesting that PtsG facili-
tates translocation of the toxin into the cytoplasm for access to the substrate. The
ABC transporters MetI, RbsC, and YciB are required for import of the nuclease effector
domains of CdiAMHI813, CdiADd3937, and CdiAo11EC869, respectively. Non-nuclease CDI
toxins also require the presence of specific IMPs for activity (26). CdiAEC93 delivers a
C-terminal effector domain that dissipates the PMF and decreases the ATP level
within target cells, suggesting that it may form pores in the membrane (31).
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However, in contrast to pore-forming colicins that depolarize target cell membranes
by spontaneously inserting into the lipid bilayer to form ion channels (32), CdiA-
CTEC93 is not active against target cells that lack AcrB, the IM drug/proton antiporter
component of the AcrAB-TolC multidrug efflux pump (26). The efflux pump activity is
not required nor are its partners, since DacrA and DtolC target cells remain sensitive
to CdiA-CTEC93. The mechanism(s) by which IMPs promote membrane insertion or
translocation of CDI toxins is unknown. Here, we identify a single amino acid substi-
tution (Ser281Phe), located deep within the channel of the universally conserved and
essential protein export conduit, SecY, which confers resistance to the E. coli PMF-dis-
sipating CdiA-CTo10EC869 toxin (one of 11 “orphan” CdiA-CT toxins encoded in the E.
coli EC869 genome, downstream of the main CdiA-CTEC869). This is the first essential
IMP identified with a role in CDI. Target cells carrying the secYS281F allele are protected
from membrane depolarization and growth inhibition during competition co-culture
with inhibitor cells despite receiving delivered CdiA-CTo10EC869. Notably, SecYS281F
does not appear to significantly affect protein translocation in vitro. The secYS281F
mutation also provides partial protection against the tRNase activity of CdiA-
CTGN05224, an EndoU RNase CDI toxin from Klebsiella aerogenes GN05224. Genetic
selection for full toxin resistance identified two additional members of the SecY
translocon, periplasmic chaperones YfgM and PpiD, that play roles in CDI toxin
import. Taken together, our data indicate that CdiA-CTo10EC869 and CdiA-CTGN05224 tox-
ins interact with the Sec translocon, effecting their insertion into and translocation
across the IM, respectively.
RESULTS
A single amino acid substitution in transmembrane helix 7 of the protein
translocase subunit SecY confers resistance to CdiA-CTo10EC869. Previously, we
showed that CdiA-CTo10EC869 inhibits the growth of E. coli target cells (29). However, the
mechanism by which the toxin enters the cell and inhibits growth was not explored.
CDI toxins require specific target cell factors for translocation and activity (18, 26, 33,
34). To identify such factors for CdiA-CTo10EC869, we used a genetic approach that we
developed previously (34). Eleven independent pools of CDI-sensitive target cells were
mutagenized by exposure to UV light and then subjected to three rounds of selection
by co-culture with CDI1 inhibitor cells expressing a CdiAEC93-CTo10EC869 chimera to enrich
for CDI-resistant (CDIR) mutants (29). Complementation analysis of one of the CDIR
mutants (M-Ec1) (see Materials and Methods; see also Table S1 at https://datadryad
.org/stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I), identified a
UCC (Ser)-to-UUC (Phe) missense mutation in secY that alters residue 281 in trans-
membrane helix 7 (TM7) of the protein (see Fig. S2 and Table S1 at the URL mentioned
above). Target cells containing the secYS281F allele were significantly protected from
growth inhibition during co-culture with inhibitor cells delivering CdiA-CTo10EC869
(compare secYS281F and secY1 target cells) (Fig. 1A). The CDI resistance observed is
specific because secYS281F cells were sensitive to growth inhibition mediated by
CdiA-CTEC93 and CdiA-CTEC869 (tRNase activity) (Fig. 1A). Subsequent sequence anal-
ysis of secY from four other independently isolated CDIR mutants revealed a UCC
(Ser)-to-UUU or UUC (Phe) mutation in all five lineages, supporting the importance
of Phe281 in CDI resistance. Mutant isolates M-Ec2, M-Ec3, and M-Ec4 each contain
additional missense mutations in secY (L423P, S68F, and V230L, respectively) (see
Table S1 at the URL mentioned above). These three CDIR mutants exhibited similar
levels of resistance to CdiA-CTo10EC869 (see Fig. S3 at the URL mentioned above),
indicating that the Ser281Phe substitution is primarily responsible for the CDI re-
sistance phenotype. Notably, the secYS281F substitution mutation was detected in
five independent UV-treated cell pools, and no other mutations were identified in
the 11 pools analyzed. The frequency of a loss-of-function mutation, as well as the
probability of having a mutation in any other gene, is far greater than that of hav-
ing a single amino acid substitution five times in the essential secY gene product,
encoded by two different base pair changes. Thus, our mutagenesis appears to be
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near saturating, suggesting that only mutations in the SecYS281 residue protect tar-
get cells from CdiA-CTo10EC869 intoxication.
The CdiIo10EC869 immunity protein that protects cells against CdiA-CTo10EC869 contains
two predicted transmembrane helices. Colicins that inhibit bacterial growth by forming
pores in the IM are neutralized by cognate immunity proteins that are integral IMPs
(10), suggesting the possibility that CdiA-CTo10EC869 might disrupt the PMF. To test this
hypothesis, we determined if the EC869o10 toxin dissipates the membrane potential,
DW, via collapse of the proton gradient of target cells using the membrane potential-
FIG 1 Evidence that SecY is a target of the PMF-dissipating CdiA-CTo10
EC869. (A) CDI1 inhibitor cells
delivering CdiA-CTo10
EC869, CdiA-CTEC93, CdiA-CTEC869, and no toxin (mock) were co-cultured for 1 h
with the indicated CDI2 target cells expressing dTomato from the chromosome at a 1:1 inhibitor-to-
target cell ratio. Competitive indexes are shown on the y axis, calculated as the ratio of inhibitor cells
to target cells at the end of the competition divided by the initial ratio. Results here, and for all
competition growth experiments, are from at least three independent experiments, shown with the
mean depicted by a solid line. Statistical significance was determined by Student’s t test
(*, P, 0.05). (B) Upper panel, representative flow cytometry histograms showing incorporation of the
membrane potential-sensitive dye DiBAC4(3) from the competition co-cultures in panel A. Lower
panel, quantitation of membrane depolarization in target cells from competition co-cultures in panel
A. Data are presented as the mean 6 standard error of the mean (SEM) for three independent
experiments. Colors in panels A and B are matched, showing the toxins delivered by inhibitor cells.
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sensitive dye DiBAC4(3) [bis-(1,3-dibutylbarbituric acid)trimethine oxonol], which enters
only depolarized cells. Target cells expressing dTomato from the chromosome were
mixed with inhibitor cells expressing CdiA-CTo10EC869, and the percentage of dTomato
fluorescent cells that incorporated the stain was investigated (see Fig. S4 at https://
datadryad.org/stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I). Flow
cytometric analysis indicated that CdiA-CTo10EC869 collapses the membrane potential,
since almost all target cells (;97%) incorporated the dye after co-culture with CDI1 in-
hibitor cells. Membrane depolarization was directly caused by the toxin, since cells
expressing the CdiIo10EC869 immunity protein were protected (Fig. 1B). Target cells
exposed to CdiA-CTEC869, which inhibits target cell growth by cleaving tRNA (29), did
not incorporate dye (Fig. 1B), demonstrating that the DiBAC4 assay specifically detects
depolarization of the membrane. Target cells containing the secYS281F mutation were
fully protected from membrane depolarization by CdiA-CTo10EC869 but were not pro-
tected from the unrelated PMF-disrupting CdiA-CTEC93 toxin (Fig. 1B) (26), showing that
secYS281F-mediated protection is specific. Taken together, these results indicate that
CdiA-CTo10EC869 dissipates DW, which is necessary for ATP production and cell growth,
and that target cells with the secYS281F allele are protected from this toxicity.
Mutation in secY also protects against RNase activity of the CdiA-CTGN05224
nuclease toxin. PMF-dissipating toxins such as CdiA-CTo10EC869 likely insert into the target
cell IM, whereas nuclease toxins must cross the IM to access and cleave target nucleic acids
in the cytosol. Previous work showed that specific target cell IMPs play critical roles in this
process (18, 26, 30). For nuclease toxins, the interaction with specific IMPs is hypothesized
to facilitate toxin translocation into the cytoplasm, and the genetic information that deter-
mines the specificity for a particular IMP is encoded within the cytoplasm entry domain
(CED), located proximal to the C-terminal toxin domain (see Fig. S1 at https://datadryad
.org/stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I) (18, 19). To deter-
mine if any CDI nuclease toxins exploit SecY to enter into the cytosol, we performed a
blast search for CdiA-CTo10EC869 orthologs to identify predicted nuclease CdiA-CTs that con-
tain entry domains similar to CdiA-CTo10EC869. Klebsiella aerogenes strain GN05224 contains
a region (NCBI accession no. NZ_LDBZ01000036) encoding a CdiA-CT with an entry do-
main that shares 36% identity with CdiA-CTo10EC869 (Pfam database ID PF04829) (see Fig.
S5A at the URL mentioned above) and a C-terminal toxin domain previously shown to
cleave tRNA during competition co-cultures (35). A phylogenic analysis generated from
the alignment of the CEDs (here chosen as the first 150 amino acids following the pretoxin
VENN domain) of 20 CdiA-CTs indicates that CdiA-CTo10EC869 and CdiA-CTGN05224 cluster into
two closely related subclades (see Fig. S5B, rectangular boxes, at the URL mentioned
above). To examine toxin import through the IM specifically, we used CDI1 inhibitor cells
expressing a CdiAEC93-CTGN05224 chimera (CDIGN05224) (35), leaving other known aspects of
CdiA-mediated effector translocation such as receptor binding and processing unchanged.
CDIGN05224 inhibitor cells outcompeted wild-type target cells as well as secYS281F target cells
(Fig. 2A). We next examined RNase activity of the CdiA-CTGN05224 at an early time point dur-
ing competition co-culture. Cleaved tRNA was detected in secY1 target cells after 30min
of incubation with CDIGN05224 inhibitor cells (Fig. 2B, lane 1). Significantly less activity was
observed in the secYS281F mutant than with secY1 cells during that same time period
(Fig. 2B, lane 5). Taken together, these results indicate that the secYS281F allele reduces entry
of a CdiA-CTGN05224, although not enough to protect target cells from growth inhibition.
SecY translocon accessory subunits PpiD and YfgM play roles in CDI toxin
import. Target cells expressing the secYS281F allele were not significantly resistant to CDI1
inhibitors delivering CdiA-CTGN05224, which could occur if CdiA-CTGN05224 interacts with dif-
ferent regions of SecY, or with another protein affected by the SecY mutation, for import.
To further explore the CdiA-CTGN05224 import pathway, we sought to identify mutations
that confer full resistance to CDIGN05224. Initially, we used a strategy similar to that which
yielded CDIo10EC869-resistant mutants, but enrichment of CDIGN05224-resistant mutants was
not observed in 16 independent mutant pools, suggesting that there are no nonessential
proteins required for CdiA-CTGN05224 activity and no single amino acid substitutions that
provide full resistance. Therefore, we instead used target cells carrying the secYS281F allele,
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which provides partial protection against tRNA cleavage mediated by CdiA-CTGN05224, for
enrichment. After three cycles of enrichment, eight independent pools contained target
cells fully resistant to CDIGN05224. To identify the mutations conferring CdiA-CTGN05224 resist-
ance, the genomes of four independent mutant isolates were sequenced and compared
to the parental strain. Three of the mutants contained null mutations in yfgM, and one
mutant contained a mutation disrupting ppiD (see Table S1 at https://datadryad.org/
stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I). Sequence analysis of
the yfgM and ppiD alleles in the remaining four independent mutant isolates showed that
FIG 2 The SecY translocon accessory proteins PpiD and YfgM play roles in EC869o10 and GN05224
CDI toxin import. CDI1 inhibitor cells delivering CdiA-CTGN05224 RNase were co-cultured with the
indicated CDI2 target cells at a 1:1 ratio. (A and B) Competitive indexes were calculated after 3 h of
co-culture (A), or total RNA was extracted after 30min of co-culture and used for Northern blot
analysis of tRNAGlu (B) The ratio of cleaved to uncleaved tRNA is indicated above each lane. (C) CDI1
inhibitor cells delivering the CdiA-CTo10
EC869 were co-cultured with the indicated CDI2 target cells at a
1:1 ratio for 3 h. Statistical significance was determined by Student's t test (*, P, 0.05).
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all had frameshift or nonsense mutations in yfgM or ppiD (see Table S1 at the URL men-
tioned above). To directly assess the roles of the yfgM and ppiD genes in CDI resistance,
we introduced in-frame deletions of yfgM and/or ppiD into secY1 and secYS281F parental
strains and performed competition co-cultures with inhibitor cells that deliver CdiA-
CTGN05224 or CdiA-CTo10EC869. Target cells carrying the secYS281F allele with an in-frame dele-
tion in yfgM (DyfgM) or ppiD (DppiD) were fully resistant to inhibitor cells delivering both
CdiA-CT toxins (Fig. 2A and C). In contrast, DyfgM and DppiD mutants, both singly and in
combination, were as sensitive to CDI as wild-type target cells. The CDI resistance
observed was toxin specific, as none of the mutant target cells exhibited resistance to the
CdiA-CTEC869 tRNase toxin (see Fig. S6 at the URL mentioned above). Target cells carrying
both the secYS281F and DppiD alleles are fully protected from CdiA-CTGN05224-mediated
RNase activity (Fig. 2B), consistent with results showing full protection from growth inhibi-
tion (Fig. 2A). PpiD and YfgM are single-pass integral membrane proteins with large peri-
plasmic domains and members of the periplasmic chaperone network (36–39). PpiD and
YfgM interact with one another, forming a complex that associates with the Sec translo-
con (36, 40, 41). PpiD and YgfM are not required to activate CdiA-CTGN05224, which exhibits
robust nuclease activity when purified and incubated with total E. coli RNA in vitro (35).
Thus, these factors appear to play roles in facilitating CdiA-CTGN05224 translocation into the
cytosol, where it has access to the RNA substrate. Because either of the genes coding for
these proteins can be deleted in a secYS281F target cell to produce CDI resistance, our
results indicate that the PpiD-YfgM complex plays a role in CDI toxin import.
The secYS281F mutation blocks CDI at a step following toxin transfer to target
cells. PpiD and YfgM are periplasmic chaperones and may possibly affect CdiA-CT sta-
bility in the periplasm after delivery through the outer membrane but before entry
into the inner membrane. Therefore, to monitor the fates of the EC869o10 and GN05224
CdiA-CT toxins post-delivery, we appended FLAG epitopes to their C-termini (Fig. 3A).
FLAG-tagged toxins retained growth-inhibitory activity (Fig. 3B). For these experiments,
CDI1 inhibitor cells and targets were mixed at a high initial cell density (optical density
at 600 nm [OD600], 2.8) and co-cultured for 1 h. Toxin delivery to siblings was avoided
by using CDI1 inhibitors expressing the heterologous OM receptor derived from
Salmonella enterica serovar Typhimurium (BamALT2), which blocks delivery of toxin (42).
Immunoblotting with anti-FLAG antibody on the same samples as those shown in
Fig. 3B revealed a band with the expected molecular weight of CdiA-CTo10EC869
(29.5 kDa) and CdiA-CTGN05224 (38.4 kDa) cleaved near the VENN sequence, only in cells
capable of self-delivery in the absence of added targets (Fig. 3C, compare the 2nd and
3rd lanes from the left). Bands corresponding to the CdiA-CT toxins were also present
in cell lysates from competition co-cultures in which susceptible (secY1), resistant
(secYS281F and secYS281FDppiD), and immune (secY1 cdiIo10EC869) target cells were added,
but not in cell lysates from competition co-cultures with bamALT2 target cells (Fig. 3C).
These results indicate that the secYS281F mutation does not prevent CdiA-CTo10EC869
transfer through the OM into cells or cleavage near the VENN sequence (19). In addi-
tion, both CdiA-CTs were detected in target cells lacking PpiD (Fig. 3C), suggesting that
the role of PpiD/YfgM is not to protect the toxins from proteases but to facilitate trans-
port into or through the inner membrane. Together, these results indicate that the
CEDs of CdiA-CTo10EC869 and CdiA-CTGN05224 likely interact directly with a cytoplasmic
membrane component(s) of the toxin import pathway involving SecY, YfgM, and PpiD.
Because CdiA toxin processing and C-terminal cleavage occur in secY, yfgM, and ppiD
mutant backgrounds (Fig. 3C), it seems likely that processing of CdiA toxins occurs dur-
ing transport through the OM or immediately after, although it is possible that cleav-
age could occur at the IM.
SecYS281F does not significantly alter general protein translocation. The secYS281F
mutation was isolated from multiple independent rounds of resistance selection, and two
different synonymous single nucleotide polymorphisms (SNPs) were identified, strongly
suggesting that the S281 residue is crucial for the CDI resistance. However, it is still possi-
ble that the mutation alters the abundance of another essential protein in the inner mem-
brane. To determine if the secYS281F mutant indirectly affected protein secretion, we tested
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the in vitro protein secretion activity of the translocons encoded by the wild-type and mu-
tant isolates. We found that the SecYS281FEG variant was fully capable of OmpA secretion
and only marginally slower than the native version (see Fig. S7A at https://datadryad.org/
stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I). Immunoblot analyses
indicated that no significant differences in protein levels could be detected in the abun-
dance of SecE or SecG between the wild type and the secYS281F mutants (see Fig. S7B at
the URL mentioned above). As a control, BamA receptor levels were compared between
the wild type and the secYS281F mutants. No significant differences in the abundance of
BamA could be observed between the strains, indicating that the SecY-dependent export
of BamA to the OM is unaffected (see Fig. S7B at the URL mentioned above). Lastly, we
performed mass spectrometry on envelope-enriched fractions of the wild type and the
secYS281F mutant to investigate if the mutation resulted in global changes of the protein
composition of the envelope. We could detect only 30% of the essential proteins secreted
by SecY (as the majority of proteins detected were cytosolic [791 out of 972]) (see Table
S2 at the URL mentioned above), but none of these proteins changed significantly
between the wild type and the secYS281F mutant (see Fig. S8 at the URL mentioned above),
suggesting that the SecYS281S mutant does not have a general deficiency in protein
FIG 3 The secYS281F mutation blocks CDI toxin activity at a step following toxin delivery. Cellular delivery of
FLAG epitope-tagged toxin domains in panels B and C were monitored by immunoblotting as described in
Materials and Methods. (A) Diagrams of the constructs used in panels B and C. (B) CDI1 inhibitor cells
delivering FLAG-tagged CdiA-CTo10
EC869-FLAG (left panel) or CdiA-CTGN05224-FLAG (right panel) were co-cultured with
the indicated CDI2 target cells at a 1:1 ratio for 1 h. Statistical significance was determined by Student's t test
(*, P, 0.05; **, P, 0.01). (C) Western blots of the samples in panel B, using an anti-FLAG antibody. For these
experiments, cells were mixed at high initial densities (OD600 = 2.8). The molecular weights of the full-length
CdiA proteins are 324 kDa and 334 kDA for CdiAEC93-CTo10
EC869-FLAG and CdiAEC93-CTGN05224-FLAG, respectively.
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secretion. Taken together, these results support the hypothesis that the secYS281F mutation
affects CDI toxin import directly.
Further genetic analysis addressing the role of SecY in CDI toxin import.
Attempts to detect a direct interaction between CDI toxins and SecY with cross-linking
experiments utilizing the FLAG epitope-tagged toxins followed by immunoblot analysis
were unsuccessful, potentially due to the transient nature of the CDI toxin-IMP interac-
tion. Therefore, we took a genetic approach to isolate mutations that provide specific re-
sistance to CdiA-CTGN05224. These mutations could potentially identify another protein
required for CdiA-CTGN05224 transport through the inner membrane, or mutations in SecY
that are allele specific for the CdiA-CTGN05224 CED domain, which would indicate a direct
interaction. We performed mutagenesis and enrichment in competition co-cultures
using CDIGN05224 inhibitor cells and either DppiD or DyfgM target cells. All resulting CDI-
resistant mutants contained single missense mutations in secY (see Table S1 at https://
datadryad.org/stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I). Three of
the mutants were resistant to CdiA-CTGN05224 but not to CdiA-CTo10EC869, thus showing
allele specificity. Whole-genome sequencing showed that none of these mutants car-
ried additional mutations in essential genes (see Table S3 at the URL mentioned
above), suggesting that the G313W, L386P, and G403R amino acid substitutions in
SecY provided resistance specifically to CdiA-CTGN05224. To verify this, we replaced
secY1 with the secYG313W allele in wild-type and DppiD or DyfgM MG1655 E. coli cells
and confirmed that a glycine-to-tryptophan substitution at residue 313 (G313W) in
either DppiD or DyfgM backgrounds (but not in the wild type) was sufficient to pro-
vide resistance to CdiA-CTGN05224 (Fig. 4A) but not to CdiA-CTo10EC869 (Fig. 4B). Viewed
from the periplasm, these residues are in a ring in the resting state (see Fig. S9 at the
URL mentioned above). Gly313 appears to be especially dynamic during protein
translocation, undergoing a conformational change between the resting and the
unlocked (43). Together, these results strongly support the hypothesis that the
secYS281F and secYG313W mutations affect CDI toxin import directly. The alternative hy-
pothesis, i.e., that each of the secY mutations affects the abundance of a different
essential inner membrane protein and that these hypothetical proteins were not
detected in our analysis of the SecY secreted envelope proteins (see Fig. S8 at the
URL mentioned above), seems very unlikely.
DISCUSSION
Following translocation through the OM, CDI toxins are cleaved at or near their con-
served (VE)NN sites and must additionally cross or enter the IM barrier to elicit growth
inhibitory activity (19). Our results here shed light on this latter step in the CDI path-
way, indicating that the CdiA-CTGN05224 toxin which cleaves tRNAs in the cytosol and
the CdiA-CTo10EC869 toxin that permeabilizes membranes, each utilize components of
the SecY translocon for their import. Visualization of FLAG epitope-tagged CdiA-
CTo10EC869 or CdiA-CTGN05224 indicated that toxin processing and transfer into the peri-
plasm occurred normally in the secYS281F mutant background, but translocation into or
through the IM was blocked. Genetic evidence indicates that SecY plays a direct role in
CDI import since resistance of the secYG313W mutant to CdiA-CTGN05224 was allele specific
(in DppiD or DyfgM backgrounds).
The secYS281F mutation was sufficient to provide full resistance against the CdiA-
CTo10EC869 toxin but not the CdiA-CTGN05224 toxin. This could be explained if the S281
residue is not only important for recognizing the CED domain of the incoming toxin
for transport but also facilitates entry of the peptide into the membrane. Thus, full re-
sistance is achieved for the membrane ionophore toxin CdiA-CTo10EC869 but not the
tRNase toxin CdiA-CTGN05224, which is still able to enter the cell, although less efficiently.
Another possibility is that the number of toxins required for toxicity is different for the
two toxins and that more toxin molecules are required to form a pore than to function
as a tRNase in the cytosol. Thus, if the mutation simply lowers the rate at which toxins
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enter the membrane or cell, the steady-state level of toxins might become too low for
toxicity.
During general protein secretion, the SecYEG translocon associates with distinct
binding partners, forming multimeric allosteric ensembles whose member constitu-
ency depends on the translocating substrate (1, 44, 45). By engaging substrate and
SecYEG, the essential and auxiliary SecY-associated factors, which include SecA, SecDF-
YajC, YidC, and PpiD-YfgM, modulate the activity of the translocon to increase the effi-
ciency of protein export and IMP biogenesis. Although YfgM and PpiD appear to play
roles in CDI toxin import in the secYS281F background, deletion of the genes coding for
these proteins had little to no effect on CDI toxin sensitivity of secY1 target cells. YfgM
and PpiD thus appear to play accessory roles with regard to SecY-mediated transloca-
tion of these toxins, analogous to their accessory roles in the general secretory path-
way. During protein translocation, the large periplasmic domain of PpiD interacts with
translocating polypeptides as they exit SecY (46), facilitating the release of newly
secreted peptides from the Sec translocon and interaction with SurA and SkpA as part
of a chaperone relay network (47). YfgM/PpiD do not appear to function to protect CDI
toxins from proteases, as the delivered CdiA-CTs were found to be equally stable in
both the wild-type and mutant cells. Therefore, it is possible that YfgM and PpiD might
help guide CDI toxins to SecY, maintaining the toxin in an unfolded, translocation-
competent state during entry into the lipid bilayer. Another possibility is that the PpiD-
YfgM complex alters the lipid environment at the SecY lateral gate, facilitating toxin
entry or translocation. Recent evidence indicates that PpiD and YidC use overlapping
FIG 4 Identification of additional residues in SecY that function in import of the GN05224 toxin in
the absence of PpiD and YfgM accessory factors. CDI1 inhibitor cells expressing the CDIo10
EC869 (A) or
CDIGN05224 (B) systems were mixed at a 1:1 ratio and co-cultured for 3 h with the indicated CDI2
target cells with the indicated mutations. Statistical significance was determined by Student's t
test (*, P, 0.05).
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binding sites on SecY and that the PpiD/YfgM chaperone complex is the most promi-
nent interaction partner of SecYEG (3). These results might explain why multiple ppiD
and yfgM mutants were identified in our screen whereas no mutations in yidC were
found.
Transient interactions with accessory factors as well as specific mutations in secY, such
as the prlA mutations (48), alter the conformational dynamics of the channel and hence
the functioning of the Sec translocon. Protein localization (prl) mutations in secY are
thought to promote an activated, translocation-competent conformational state in the ab-
sence of signal sequence binding, permitting the export of preproteins with defective or
missing signal peptides (41–46, 48). For example, prlA4 suppresses the growth defect of a
lamB14D mutant lacking a functional maltodextrin transporter signal sequence in cells
plated on dextrin minimal agar. Cells carrying the secYS281F allele that confer CDI resistance
have no apparent defects in protein export. Unlike prlA mutant cells, secYS281F cells were
unable to export signal sequence-defective LamB polypeptides (see Fig. S10A at https://
datadryad.org/stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I). The S281F
substitution does not appear to trigger the channel for protein export, and the
amino acid substitutions encoded by the prlA alleles we tested that do induce a
translocation-ready conformation of SecY did not provide protection against the
EC869o10 and GN05224 CDI toxins (see Fig. S10B at the URL mentioned above).
Together, these observations indicate that SecY functions in toxin import are differ-
ent from its normal protein export functions.
We recently showed that CdiA toxin processing via C-terminal cleavage occurs only
after binding to the cognate outer membrane receptor (19). Nuclease CdiA-CTs enter
the periplasm upon receptor binding regardless of the metabolic state of the receiving
cell but require the PMF for transport through the IM into the cell cytosol (29). Our
data here show that C-terminal cleavage of CdiA occurs in the secYS281F mutant back-
ground in which toxin import is blocked and the released C-terminal toxin is stable
enough to detect. Thus, toxin cleavage seems to occur independently from transloca-
tion across the IM, indicating that translocation across the inner and outer membranes
can be disconnected. In contrast to CDI, colicins require the PMF for translocation
across the OM, and processing of the nuclease domain of colicins ColE2-E3 and ColD
occurs during transport through the inner membrane (49, 50). Our results indicate that
CdiA-CT transport is distinct from these colicins, but it cannot be ruled out that the
cleavage occurs during transport through the inner membrane but that the CdiA-CTs
become stalled in the IM during the translocation event in mutant cells.
CdiA-CTo10EC869 and CdiA-CTGN05224 appear to utilize at least part of the SecY translo-
con for import through the IM of target cells. One possible mechanism is that toxins fol-
low a retrograde pathway through the SecYEG channel, interacting with TM7 of SecY. If
toxins are delivered into targets in the unfolded state, they may be able to thread into
the export channel by using energy from the proton gradient, which we showed previ-
ously is required for toxin import (29). Recently, Corey et al. demonstrated that mem-
brane-bound cardiolipin, an anionic phospholipid, is required for the PMF enhancement
of protein translocation through the SecYEG translocon (51). If the toxins follow a retro-
grade transport pathway, however, the PMF component they harness must be distinct
from that of protein export, because CdiA-CTo10EC869 and CdiA-CTGNO5224 are fully active
against cells lacking cardiolipin (see Fig. S11 at https://datadryad.org/stash/share/9S
_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I). Alternatively, CDI toxins might travel
through an encapsulated lipid microenvironment generated by the arrangement of indi-
vidual subunits within Sec translocon subassemblies. Recent small-angle neutron scatter-
ing of the YidC-SecYEG-SecDF holotranslocon confirmed a central lipid-filled core
located between SecY and YidC at the lateral gate of SecY (52). The PpiD-YfgM complex,
which is the predominant interacting partner of the SecYEG translocon, uses overlapping
SecY-binding sites to YidC and thus could affect the lipid environment at the lateral gate
similarly (3). Previous work showed that cholera toxin binding to its receptor perturbs
lipid packing, and these changes in lipid “texture” are transmitted to the inner leaflet of
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the membrane (53). This type of lipid alteration, possibly in combination with steric
changes in the Sec translocon subassemblies during protein export, might aid peptide
transit at the lipid-SecYEG protein interface. Further investigation is required to deter-
mine whether the substitutions in SecY that confer CDI resistance are in residues that
directly contact the importing toxin polypeptide or indirectly affect the conformational
plasticity of SecY, abrogating its function in toxin import.
Some bacterial pathogens express mammalian cell-targeting AB toxins that, like the
GN05224 CDI toxin, must be imported into the cytosol for activity. These toxins are
routed via retrograde transport to the endoplasmic reticulum (ER) before entering the
cytosol (54). Once in the lumen of the ER, the catalytic A subunit of several AB toxins
engage components of the ER-associated degradation (ERAD) pathway, which usually
targets misfolded proteins in the ER to the cytosol for proteolysis. AB toxins of this sub-
group appear to hijack membrane-embedded channels, possibly including the Sec61
(SecY homolog) translocon (55). Notably, these AB toxins interact with ERAD-associated
chaperones, which disassemble the AB subunits, unfold the catalytic A domain, and
maintain it in a translocation-competent state (56–59). Thus, the co-opting of cellular
protein translocation-associated chaperones and channels by bacterial toxins appears
to occur in both the prokaryotic and eukaryotic kingdoms.
MATERIALS ANDMETHODS
Bacterial and CDI competition co-cultures. Bacterial strains are shown in Table S4 at https://
datadryad.org/stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I. Bacteria were grown at
37°C in LB medium or on LB agar unless otherwise noted. Media were supplemented with antibiotics at
the following concentrations: ampicillin (AMP), 150mg ml21; kanamycin (KAN), 40mg ml21; chloram-
phenicol (CAM), 12.5, 34, or 60mg ml21; and spectinomycin (SPEC), 50mg ml21.
For liquid competition co-cultures, inhibitor and target cells were grown to mid-logarithmic phase
and then mixed at a 1:1 ratio in medium without antibiotics. Co-cultures were incubated for the times
indicated (1 h or 3 h) at 37°C with shaking at 225 rpm in baffled flasks. Viable inhibitor and target cells
were counted as CFU on selective LB agar. Spin down competition co-cultures were used when target
cells had different growth rates (see Fig. S5 and S10 at the URL indicated above). For spin down competi-
tion co-cultures, inhibitor and target cells were grown to mid-log phase and then mixed at a 1:1 ratio in
medium without antibiotics in a 1.5-ml Eppendorf tube. Cells were centrifuged at 300 g for 2 min. Cell
pellets were then resuspended. Viable inhibitor and target cells were enumerated as CFU on selective LB
agar. The competitive index (CI) was calculated as the ratio of inhibitor to target cells after centrifugation
divided by the initial inhibitor-to-target cell ratio.
Isolation of resistant mutants. To generate CDI-resistant mutants, target cells were UV mutagen-
ized and selected for as previously described (34). The CdiAEC93-CTo10
EC869 and CdiAEC93-CTGN05224 chime-
ras bind to the OM receptor BamA. To avoid isolating mutations in bamA, we introduced a bamA1 multi-
copy plasmid (see Table S5 at the URL mentioned above) into target cells prior to mutagenesis. Each
mutant pool was subjected to selection by co-culture with E. coli EPI100 inhibitor cells carrying
pCH10166 or pDAL8914. The surviving colonies were collected and subjected to two more rounds of co-
culture selection. After three rounds of selection, individual colonies were picked and tested for resist-
ance. Mutations in resistant colonies were determined through complementation with cosmid libraries
or through whole-genome sequencing. For detailed analysis of these methods, see the appendix at
https://datadryad.org/stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I.
Membrane potential measurements. Overnight cultures of target and inhibitor cells were diluted
1:100 into fresh LB broth and grown to an OD600 of 1.0 (or approximately 5 107 CFU/ml) and mixed at
a ratio of 1:1. After 1 h of co-culture, an aliquot of 150ml was moved to a 1.5-ml Eppendorf tube, and
10mg/ml of DiBAC4(3) was added. Cells were incubated at 37°C with shaking for another 30 min. Single-
cell fluorescence was measured using a MACSQuant VYB (Miltenyi Biotec). DiBAC4(3) was excited at
488 nm, and its fluorescence was measured on the B1 channel (filter 525/50 nm). dTomato was excited
at 561 nm, and its fluorescence was measured on the Y2 channel (filter 615/20 nm). A total of 100,000
events were collected. Raw flow cytometry data analysis was performed with the FlowJo data analysis
software program (FLOWJO LLC, Ashland, OR).
Detailed descriptions of the construction of E. coli strains (Table S4), plasmids (Table S5), oligonucleo-
tides (Table S6), maltodextrin selection, cosmid library construction, complementation, genome sequenc-
ing, immunoblotting, and RNA analysis are provided in the appendix at the URL mentioned above.
Data availability. All data and methods discussed in this paper are available in the main text and in
the appendix at https://datadryad.org/stash/share/9S_XL1c_3LqEvKDWKAAY8jnB44PNTbcLmUsf1tJdK0I.
Raw data for growth competition experiments are shown in Table S7, and all supplemental information
referenced in this paper is available through Dryad at the URL mentioned above.
Detailed protocols are available from S.K. or D.A.L. upon request.
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